Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous scle

  • PDF / 3,493,589 Bytes
  • 12 Pages / 595.276 x 790.866 pts Page_size
  • 97 Downloads / 154 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement? Anne-Lise Gaillard 1 & Amandine Crombé 2,3 & Vincent Jecko 4 & Pierre Bessou 1 & Marion Havez 1 & Jean-Michel Pédespan 5 & Julien Van Gils 6 & Jean-François Chateil 1,7 Received: 27 November 2019 / Revised: 8 March 2020 / Accepted: 5 May 2020 # Springer-Verlag GmbH Germany, part of Springer Nature 2020

Abstract Background Subependymal giant cell astrocytomas (SEGAs) arise in 10–26% of tuberous sclerosis complex (TSC) patients. SEGAs cause obstructive hydrocephalus and increase morbi-mortality. It is recommended that TSC patients be followed with contrast enhanced magnetic resonance imaging (CE-MRI), but repetitive use of gadolinium-based contrast-agents (GBCAs) may cause organ deposits. Objective To compare the diagnostic performances of non-CE- and CE-MRI to differentiate SEGAs from subependymal nodules in TSC patients during follow-up. Materials and methods Thirty-five TSC patients (median age: 2.4 years) were enrolled in this retrospective single-center study from September 2007 to January 2019. Inclusion criteria were a certain diagnosis of TSC and at least three follow-up brain MRIs with GBCA injection. Two consecutive MRI scans per patient were selected and anonymized. Three radiologists performed a blinded review of non-enhanced and enhanced MRI sequences during different sessions. The diagnostic performances were compared (sensitivity, specificity, positive/negative predictive values, accuracy, inter/intra-observer agreements). Results The accuracies for detecting SEGAs were good and similar between the non-enhanced and enhanced MRI sequences. The sensitivity and specificity of non-CE-MRI to diagnose SEGA ranged from 75% to 100% and from 94% to 100%, respectively. The differences in numbers of false-positive and false-negative patients between non-CE- and CE-MRI never exceeded one case. Nodules size >10 mm, location near the Monro foramen, hydrocephalus and modifications between two consecutive MRI scans were significantly associated with the diagnosis of SEGA for the three readers (all P-values